Alogliptin Impurity 12 is a pharmaceutical intermediate used in the manufacturing process of alogliptin, a compound for diabetes research. It is a structurally defined chemical with multiple ring systems and functional groups.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2749281-73-8
N-Acetyl alogliptin
Pharmaceutical intermediate or metabolite
N-Boc Alogliptin
active pharmaceutical ingredient
3-(2-Cyanobenzyl) Alogliptin
pharmaceutical intermediate
Alogliptin Impurity 70
pharmaceutical intermediate for alogliptin
5-Aminopyrazole-4-carboxamide hemisulphate
Pharmaceutical intermediate for allopurinol impurities
N-(4-Oxocyclohexyl)acetamide
pharmaceutical intermediate
(s)-2-(1-aminoethyl)-5-bromophenol hydrochloride
Pharmaceutical intermediate
Glycine tert-butyl ester hydrochloride
Pharmaceutical intermediate for peptide synthesis
N-[(3R)-1-[3-[(2-cyanophenyl)methyl]-1-methyl-2,6-dioxopyrimidin-4-yl]piperidin-3-yl]benzamide
YJMNTJGSDFBRQM-OAQYLSRUSA-N
CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)NC(=O)C4=CC=CC=C4